2012 China New Medical Reform Policy Specific Analysis and the Influence on Medical Industry

• Publication date: November 2012
• Report size: 63 pages

The report is concentrated on the implementation of China New Medical Reform Policy and its influence on China medicine industry. The report analyzes the forthcoming National Essential Medicine List 2012 and conducts a statistics work on provinces added list. Besides, it also had a specific analysis on marketing channel of China medicine enterprises under New Medical Reform Policy. Generally, the report can provide advantageous reference for insi...

The report is concentrated on the implementation of China New Medical Reform Policy and its influence on China medicine industry. The report analyzes the forthcoming National Essential Medicine List 2012 and conducts a statistics work on provinces added list. Besides, it also had a specific analysis on marketing channel of China medicine enterprises under New Medical Reform Policy. Generally, the report can provide advantageous reference for insiders and help you understand comprehensively China's current health reform process.

Drug And Medication Industry in China

1. China New Medical Reform Policy Specific Analysis
1.1 Medical Reform History
1.1.1 Reasons of the Past Fail Cases
1.1.2 Basic Medical and Health System Mode of New Medical Reform Policy
1.1.3 Phasic Results of Three-year of Medical and Health Reform
1.2 Primary Care and Public Health Solve “Treatment Difficulty”
1.2.1 Reasons of “Treatment Difficulty”
1.2.2 Measures to Solve “Treatment Difficulty”
1.3 Medical Insurance, Basic Medicines, and Public Hospitals Reform Solve “Treatment Expensiveness”
1.3.1 Reasons of “Treatment Expensiveness”
1.3.2 Measures to Solve “Treatment Expensiveness”
1.4 New Medical Reform Policy Influence on Medical Enterprises
1.4.1 Opportunities and Challenges Brought by Medical Reform to Medical Enterprises
1.4.2 Influence of Medical Reform on Foreign Investment and Joint Ventures’ Market Share
1.4.3 Organization of Medical and Health Reform in 2012
1.4.4 New Medical Reform Policy Shows Clearly the Future Direction of the Medical Reform
1.5 Influence of Medical Reform on Foreign Owned, Joint Ventures and China State-owned Enterprises
1.5.1 Influence on Foreign Owned Enterprises
1.5.2 Influence on Joint Ventures
1.5.3 Influence on China State-owned Enterprises
1.6 Strategy Analysis of Joint Ventures Coping with New Medical Reform Policy
1.6.1 Attach Importance to the Research and Development of Chinese Medicine and Patent Medicines
1.6.2 Pay Attention to the Medicine Needs of the Rural and Community
1.6.3 Adjust Strategy to Adapt to the Flat Channel
1.7 Industrial Pattern of Medicine Enterprises
1.7.1 Current Industrial Merger & Acquisition
1.7.2 Industry Concentration Ratio Planning during the “Twelfth Five-Year” Period
1.8 Forecast and Influence of Drug Code Adjustment in the Future
1.8.1 Comprehensive Check of the Drug Approval Number after the Implementation of New Medical Reform Policy
1.8.2 Drug Registration Approval Data Interpretation, 2008-2011
1.8.3 The “Twelfth Five-Year” Plan Required to Further Give Full Play to the Role of Drug Regulation

2. Medicine Marketing Channel Change under New Medical Reform
2.1 Marketing Channel of Medicine Enterprise
2.1.1 Main Marketing Channel of Different Medicine Categories
2.1.2 Original Marketing Channel
2.1.3 Development Trend of Marketing Channel
2.2 Influence of New Medical Reform Policy on Medicine Marketing
2.2.1 Expansion of Market Capacity and Surge of Generic Medicine Market
2.2.2 Change of Terminal Market and Rise of the Third Terminal
2.2.3 Much More Professional Marketing Mode
2.3 Influence of New Medical Reform Policy on Medicine Enterprises’ Marketing Channel
2.3.1 Influence on Foreign Owned Enterprises
2.3.2 Influence on Joint Ventures
2.2.3 Influence on China Domestic Enterprises
2.4 Joint Ventures’ Marketing Strategy under New Medical Reform
2.4.1 In Accordance With Polarization of Medicine Market
2.4.2 Enhance Marketing Activity with the Help of Commercial Channels
2.4.3 Improve the Quality of Employees via Professional Training
2.4.4 Organic Combination of Academic and public welfare

3. The Latest National Essential Medicine List and the Provinces Added List
3.1 Interpretation of New Version of the National Essential Medicine List
3.1.1 The Leadership of the Ministry of Health’s Interpretation of New Version of the National Essential Medicine List
3.1.2 Interpretation of Informal Version of National Essential Medicine List
3.2 Provinces Added List

Drug and Medication in China

Number Of Enterprises-drug_gap Certification For Chinese Herbal Medicine-china-annual, In Unit (units)

• $ 250
• Industry data
• May 2013

Yearly, From 2006 To 2011
By Chinascope Financial
Source: Chinascope Financial

• Industries : Drug and Medication
• Countries : China

China Pharmaceutical Sales, Us$bn

• $ 250
• Industry data
• January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: Southern Medicine Economic Institute (SMEI), Association of the European Self-Medication Society (AE

• Industries : Drug and Medication
• Countries : China

China Pharmaceutical Sales, Us$bn, % Chg Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2005 To 2021
By Business Monitor International
Source: Southern Medicine Economic Institute (SMEI), Association of the European Self-Medication Society (AE

• Industries : Drug and Medication
• Countries : China

China Pharmaceutical Sales, Cnybn

• $ 250
• Industry data
• January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: Southern Medicine Economic Institute (SMEI), Association of the European Self-Medication Society (AE

• Industries : Drug and Medication
• Countries : China

China Pharmaceutical Sales, Cnybn, % Chg Y-o-y

• $ 250
• Industry data
• January 2013

Yearly, From 2005 To 2021
By Business Monitor International
Source: Southern Medicine Economic Institute (SMEI), Association of the European Self-Medication Society (AE

• Industries : Drug and Medication
• Countries : China